Announced
EMS to acquire a 20% stake in Hypera for $678m.
Synopsis
EMS, a pharmaceutical company, offered to acquire a 20% stake in Hypera, a drug manufacturer in Brazil, for $678m. The leadership of both Hypera and EMS agrees that the industrial combination is undeniably beneficial, as it would solidify their position as market leaders with a 17% market share.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.